当前位置:首页 - 行情中心 - 珈凯生物(920165) - 财务分析 - 现金流量表

珈凯生物

(920165)

  

流通市值:3.26亿  总市值:16.39亿
流通股本:960.50万   总股本:4827.44万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金162,259,032.0571,750,982.55292,186,212.55207,271,449.57
  收到的税费返还8,968,529.685,982,191.264,374,643.664,830,263.17
  收到其他与经营活动有关的现金2,374,454.44945,484.064,548,470.653,509,187.85
  经营活动现金流入小计173,602,016.1778,678,657.87301,109,326.86215,610,900.59
  购买商品、接受劳务支付的现金54,985,159.0420,848,085.2384,709,456.6563,120,184.5
  支付给职工以及为职工支付的现金37,415,692.6623,917,569.9759,148,394.3848,928,110.31
  支付的各项税费23,665,135.1910,242,234.8636,219,257.8226,116,354.1
  支付其他与经营活动有关的现金15,720,121.038,246,157.5629,502,980.2522,209,607.15
  经营活动现金流出小计131,786,107.9263,254,047.62209,580,089.1160,374,256.06
  经营活动产生的现金流量净额41,815,908.2515,424,610.2591,529,237.7655,236,644.53
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额1,373,481.8116,213.0558,256.6458,256.64
  收到的其他与投资活动有关的现金390,432,736.47190,233,112.64378,506,028.26253,336,983.57
  投资活动现金流入小计391,806,218.27190,349,325.69378,564,284.9253,395,240.21
  购建固定资产、无形资产和其他长期资产支付的现金6,258,749.733,639,730.3514,937,617.0512,890,408.15
  支付其他与投资活动有关的现金360,000,000160,000,000438,000,000283,000,000
  投资活动现金流出小计366,258,749.73163,639,730.35452,937,617.05295,890,408.15
  投资活动产生的现金流量净额25,547,468.5426,709,595.34-74,373,332.15-42,495,167.94
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金---67,475.24
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---67,475.24
  偿还债务支付的现金--200,000200,000
  分配股利、利润或偿付利息支付的现金144,083.3471,25031,162,471.9931,090,430.33
  支付其他与筹资活动有关的现金764,058607,0294,812,2004,962,649.99
  筹资活动现金流出小计908,141.34678,27936,174,671.9936,253,080.32
  筹资活动产生的现金流量净额-908,141.34-678,279-36,174,671.99-36,185,605.08
四、汇率变动对现金及现金等价物的影响-650,182.65-228,122.2483,978.91133,751.73
五、现金及现金等价物净增加额65,805,052.841,227,804.35-18,934,787.47-23,310,376.76
  加:期初现金及现金等价物余额58,996,515.8358,996,515.8377,931,303.377,931,303.3
  期末现金及现金等价物余额124,801,568.63100,224,320.1858,996,515.8354,620,926.54
补充资料:
  净利润37,571,648.64-66,269,300-
  资产减值准备1,000,673.25-351,400-
  固定资产和投资性房地产折旧9,652,068.96-19,178,200-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧9,652,068.96-19,178,200-
  无形资产摊销854,412.12-1,689,300-
  长期待摊费用摊销487,720.48-669,900-
  处置固定资产、无形资产和其他长期资产的损失--189,100-
  固定资产报废损失--26,200-
  公允价值变动损失13,972.6--24,700-
  财务费用823,146.93-332,000-
  投资损失-432,736.47--506,000-
  递延所得税-376,418.01-317,000-
  其中:递延所得税资产减少-345,369.41-371,200-
    递延所得税负债增加-31,048.6--54,200-
  存货的减少-11,820,769.65-24,100-
  经营性应收项目的减少-1,810,769.92-433,200-
  经营性应付项目的增加3,654,703.6--518,000-
  其他--2,992,100-
  现金的期末余额124,801,568.63---
  减:现金的期初余额58,996,515.83---
  现金及现金等价物的净增加额65,805,052.8--18,934,787.47-
公告日期2026-08-202026-04-212026-03-202025-11-10
审计意见(境内)标准无保留意见
TOP↑